Viagra gibt es mittlerweile nicht nur als Original, sondern auch in Form von Generika. Diese enthalten denselben Wirkstoff Sildenafil. Patienten suchen deshalb nach viagra generika schweiz, um ein günstigeres Präparat zu finden. Unterschiede bestehen oft nur in Verpackung und Preis.
Eymj.org
 Yonsei Med J 53(4):842-848, 2012
pISSN: 0513-5796, eISSN: 1976-2437
Fluoxetine Protects against Big Endothelin-1 Induced 
Anti-Apoptosis by Rescuing Kv1.5 Channels in Human 
Pulmonary Arterial Smooth Muscle Cel s
FeiFeng Dai, ZhiFu Mao, Jun Xia, ShaoPing Zhu, and ZhiYong Wu
Department of Cardiothoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Received: September 7, 2011
Purpose: Pulmonary Kv channels are thought to play a crucial role in the regulation 
Revised: October 14, 2011
of cel proliferation and apoptosis. Previous studies have shown that fluoxetine up-
Accepted: October 24, 2011
regulated the expression of Kv1.5 and prevented pulmonary arterial hypertension in 
Corresponding author: Dr. ZhiFu Mao,
monocrotaline-induced or hypoxia-induced rats and mice. The current study was de-
Department of Cardiothoracic Surgery, 
signed to test how fluoxetine regulates Kv1.5 channels, subsequently promoting 
Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuchang District, 
apoptosis in human PASMCs cultured 
in vitro. 
Materials and Methods: Human 
Wuhan 430060, China.
PASMCs were incubated with low-serum DMEM, ET-1, and fluoxetine with and 
Tel: 86-027-88041911-82230 
without ET-1 separately for 72 h. Then the proliferation, apoptosis, and expression of 
Fax: 86-027-88042292
TRPC1 and Kv1.5 were detected. 
Results: In the ET-1 induced group, the upregula-
tion of TRPC1 and down regulation of Kv1.5 enhanced proliferation and anti-apop-
∙ The authors have no financial conflicts of 
tosis, which was reversed when treated with fluoxetine. The decreased expression of 
TRPC1 increased the expression of Kv1.5, subsequently inhibiting proliferation 
while promoting apoptosis. 
Conclusion: The results from the present study suggest-
ed that fluoxetine protects against big endothelin-1 induced anti-apoptosis and res-
cues Kv1.5 channels in human pulmonary arterial smooth muscle cel s, potential y 
by decreasing intracel ular concentrations of Ca2+.
Key Words: Apoptosis, Kv1.5, human pulmonary arterial smooth muscle cel s
The development of pulmonary arterial hypertension (PAH) involves a complex constel ation of multiple genes and molecules, which interact with each other and subsequently activate intracel ular signaling pathways that eventual y result in pul-monary remodeling. Vascular remodeling has been confirmed to be a hal mark pathological feature of PAH, and is characterized by changes in the pulmonary vascular structures associated with medial hypertrophy, which are mainly caused 
by an imbalance between the proliferation and apoptosis of pulmonary arterial 
Yonsei University Col ege of Medicine 2012
smooth muscle cel s (PASMCs).
This is an Open Access article distributed under the 
Pulmonary Kv channels are thought to play a crucial role in the regulation of cel 
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/ 
proliferation and apoptosis. K+ fluxes have been implicated in both the early and 
licenses/by-nc/3.0) which permits unrestricted non-
late stages of apoptosis, as the down regulation of Kv has been shown to induce in-
commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
creases in intracel ular K+ concentrations ([K+]i) and tonical y inhibit caspase, fur-
Yonsei Med J http://www.eymj.org Volume 53 Number 4 July 2012
Fluoxetine Rescues Kv1.5
ther suppressing apoptosis. As shown in human and animal 
ShangHai, China), and fluoxetine (F; Sigma-Aldrich, Shang-
models of PAH, resistance to apoptosis was further en-
Hai, China) with and without ET-1 separately for 72 hours.
hanced by the selective downregulation of Kv1.5 chan-nels.1-3 However, increases in Kv channel activity and ex-
MTT assay 
pression have been widely associated with apoptotic 
Cel proliferation was quantified by multiply-table tourna-
induction. And a previous study confirmed that the upregu-
ment (MTT) assay. Briefly, human PASMCs were plated 
lation of Kv1.5 was correlated with an increase in apoptosis 
into 96-wel microplates at the concentration of 2×103 cel s/
and inhibition of PAH.1,4
well and treated with the different drugs as described 
Endothelin-1 (ET-1) has been implicated in the pathogen-
above. After incubation, 20 μL of the MTT reagent was 
esis of pulmonary hypertension. And, there was clear evi-
added to each wel and the multiwel plates were incubated 
dence of activation of the ET system in virtual y al pre-clin-
in a humidified atmosphere for 4 hours. Then, the superna-
ical models of PAH, as wel as in al categories of human 
tant was removed from each wel and 200 μL/wel of di-
PAH.5 Its levels have been shown to be closely correlated 
methyl sulfoxide (DMSO; Sigma-Aldrich, St. Louis, MO, 
with the severity of pulmonary vascular remodeling.6 Inter-
USA) was added to solubilize the formed formazan salt 
estingly, it was reported that extracellular application of 
crystals. The solubilized formazan product was spectropho-
ET-1 significantly reduced the amplitude of currents gener-
tometrical y quantified at 570 nm using an ELISA reader 
ated by K+ efflux through Kv1.5 channels. The inhibitory 
(Biorad, Hercules, CA, USA). Data were expressed as a % 
effect of ET-1 on Kv1.5 channels provided convincing evi-
of the control.
dence that the mitogenic effect of ET-1 may partial y result from its inhibition of Kv1.5 channels in human PASMCs.7
Reverse transcription-polymerase chain reaction
Fluoxetine, the highly selective 5-hydroxytryptamine 
Total RNA was isolated from human PASMCs using TRIzol 
transporter (5-HTT) inhibitor, was reported to confer partial 
reagent (Sigma-Aldrich, St. Louis, MO, USA) according to 
protection from PAH in chronical y hypoxic mice.8 Intrigu-
the manufacturer's instructions. The specific primers were 
ingly, fluoxetine was recently reported to prevent and re-
designed from the coding regions of human Kv1.5 (forward 
verse established PAH in monocrotaline (MCT)-induced 
primer: 5'-TCCT CCG AGTCATCCG-3', reverse primer: 
hypertensive rats.9-11 In addition, it was also reported that 
5'-ACAGCGAGCCCACGATC-3'). As a control for the in-
the protective effect of fluoxetine against MCT-induced hy-
tegrity of RNA, the primers of glyceraldehydes phosphate 
pertension was potential y by upregulating Kv1.5 channels 
dehydrogenase (GAPDH) were used (forward primer: 5'-A 
in rat. Therefore, the current study was designed to test the 
GGTGAAGG TCGGAG TCAAC-3' and reverse primer: 
hypothesis that the antiproliferative and protective effects 
5'-CGCTCCTGGAAGATGG TGAT-3'). Amplified prod-
of fluoxetine are partial y due to the upregulation of Kv1.5 
ucts were separated by 1.2% agarose gel electrophoresis 
channels and subsequent promotion of apoptosis in human 
and stained with ethidium bromide. PCR product bands 
PASMCs cultured 
in vitro.
were visualized by ultra violet light, and the intensity val-ues were measured by densitometric analysis with the Quantity One program (Bio-Rad) and normalized to the in-
MATERIALS AND METHODS
tensity values of GAPDH for quantitative comparisons. 
The PCR product was sequenced and the amplified produc-
Cel preparation and culture
tion of human Kv1.5 and GAPDH were 306 and 232 bp, 
Human PASMCs from normal subjects were purchased from 
ATCC (Rockefel er, Mali organization, Manassas, VA, USA) and used at passages 6-8. PASMCs were cultured in Dulbec-
co's Modified Eagle Medium (DMEM) supplemented with 
After 72 hours, cel s were harvested in cel lysis solution 
10% fetal bovine serum (FBS), and maintained at 37°C in a 
(BioDev-Tech. Company, Beijing, China); then protein was 
humidified atmosphere of 5% CO2 in air. The growth of the 
extracted. The resultant protein concentrations were deter-
cel s was arrested by replacing 10% FBS DMEM with FBS-
mined by BCA Protein Assay reagents (Beyotime Biotech-
free DMEM for 24 hours. The cel s were then incubated 
nology, Jiangsu, China). The extracts were diluted in 5× 
with low-serum DMEM (2% FBS), ET-1 (Enzo ALEXIS, 
loading buffer and heated at 95°C for 5 minutes. Kv1.5 and 
Yonsei Med J http://www.eymj.org Volume 53 Number 4 July 2012
FeiFeng Dai, et al.
TRPC1 proteins were detected using a standard Western blot 
as 100%, and the results for the ET-1, F with or without ET-1 
protocol. Briefly, 30 μg proteins were separated by 8% SDS 
groups were expressed as a percentage of the value from the 
PAGE at 100 V for 0.5 hour and 80 V for 1.5 hours, and then 
Blank group.
transferred to a nitrocel ulose membrane (Mil ipore, Bil eri-ca, MA, USA) at 4°C, 200 mA for 1 hour by a Western blot 
apparatus (Bio-Rad). The transferred membrane was blocked 
Al samples were immunostained according to the protocol 
with 10% skimmed milk for 1 hour at room temperature, and 
of the Annexin V/PI apoptosis kit. The apoptosis ratio was 
then the blocked membrane was incubated with a primary 
analyzed using flow cytometry.
antibody against Kv1.5 (dilution 1 : 700; Santa Cruz Bio-technology, Santa Cruz, CA, USA), TRPC1 (dilution 1 : 400; 
Santa Cruz Biotechnology) and GAPDH (dilution 1 : 700; 
Al data are expressed as the mean±SEM. Al experiments 
Santa Cruz Biotechnology) overnight at 4°C, respectively. 
were performed at least with six independent Human PASMCs 
After incubation with the horseradish peroxidase-conjugated 
cultures. Statistical analyses were performed by one-way 
secondary antibody (dilutions of 1 : 5000; Beijing Zhong 
ANOVA. 
p-values <0.05 were considered significant.
Shan-Golden Bridge Biological Technology Company, Bei-
jing, China) for 1 hour at room temperature, the immunoblot-
ting signals were visualized using a Western Luminescent Detection kit (Vigorous Biotechnology, Beijing, China). The 
results were quantified by densitometry and the density of 
Fluoxetine suppresses ET-1 induced human PASMCs 
immunoblot ing was analyzed by scanning X-ray film with 
Quantitative One software. The values of the relative density 
Plasma and lung ET-1 expression were increased in PAH, 
of the Kv1.5 and TRPC1 bands were normalized to the den-
and correlated with disease severity, including the degree of 
sity of GAPDH to represent the amount of Kv1.5 and 
PASMC proliferation.17 Fig. 1 shows the time course of hu-
TRPC1 protein. The ratio of the Blank group was regarded 
man PASMC proliferation mediated by 2% FBS (Blank) 
 E (0.1) with F (1.0) (µM)
Fig. 1. Fluoxetine mediated anti-proliferation of human PASMCs against ET-1. (A) Time course of the 2% FBS (Blank) and ET-1 (0.01 to 1 μM) induced human 
PASMCs proliferation (B). (C) The anti-proliferation of fluoxetine in a dose-dependent manner against ET-1 (0.1 μM). (D) The approximate proliferation be-
tween the 2% FBS and fluoxetine (1.0 μM) treated groups, induced by ET-1 (0.1 μM ). PASMCs, pulmonary arterial smooth muscle cel s; FBS, fetal bovine se-
rum; ET-1, endothelin-1; MTT, multiply-table tournament.
Yonsei Med J http://www.eymj.org Volume 53 Number 4 July 2012



Fluoxetine Rescues Kv1.5
(Fig. 1A) and ET-1 at concentrations of 0.01 to 1 μM (Fig. 
1B). As shown in Fig. 1C, fluoxetine inhibited ET-1 (0.1 μM)-
mediated increase of human PASMC numbers at the concen-trations of 0.1 to 10 μM. Since the concentration of 1 μM fluoxetine suppressed proliferation approximately to that of 
seen in 2% FBS (Blank), shown in Fig. 1D, this concentra-tion was used as the proper inhibitory dose. So, the final 
concentrations of ET-1 and fluoxetine were set at 0.1 μM 
and 1.0 μM, separately. 
Fluoxetine suppresses ET-1 induced upregulation of 
TRPC1 in human PASMCs
TRPC1 protein level 0.3
It has been reported that the activity and expression level of 
TRPC1 protein is directly correlated to [Ca2+]i. In the present study, fluoxetine suppressed the expression of the TRPC1 
Fig. 2. Fluoxetine down regulated the expression of TRPC1 protein in ET-1 
induced human PASMCs. Western blot results are displayed for TRPC1 (92 
protein induced by ET-1. In Fig. 2, the expression of the 
kDa) and GAPDH (34 kDa) in the human PASMCs cultured with low-serum 
TRPC1 markedly increased in the ET-1 induced group com-
DMEM (2% FBS, Blank), ET-1, and fluoxetine with (ET-1+F) and without ET-1 
(F) for 72 hours. Data, normalized to the amount of actin, are expressed as 
pared with the Blank (1.2448±0.2157 vs. 0.6572±0.1076, 
mean±SEM (n=7). *p<0.01 vs. Blank, †p<0.05 vs. ET-1. PASMCs, pulmonary 
p<0.01). However, when treated with fluoxetine, it was down 
arterial smooth muscle cel s; FBS, fetal bovine serum; TRPC, transient re-
ceptor potential channels; ET-1, endothelin-1; GAPDH, glyceraldehydes 
regulated in the ET-1 induced group (0.7904±0.1043 vs. 
phosphate dehydrogenase; SEM, standard error of mean.
1.2448±0.2157, p<0.05). 
Fluoxetine upregulates the expression level of Kv1.5 in 
ET-1 mediated human PASMCs
Pulmonary Kv1.5 channels are supposed to play a key role in 
Kv1.5 protein level
Fig. 3. Fluoxetine rescued the expression of Kv1.5 mRNA that was down 
Fig. 4. Fluoxetine reversed the level of Kv1.5 protein in ET-1 induced human 
regulated by ET-1 in human PASMCs. PCR amplified products are dis-
PASMCs. Western blot results are displayed for Kv1.5 (57-59 kDa) and 
played for Kv1.5 (306 bp) and GAPDH (232 bp) in the human PASMCs cul-
GAPDH (34 kDa) in the human PASMCs cultured with low-serum DMEM 
tured with low-serum DMEM (2% FBS, Blank), ET-1, and fluoxetine with 
(2% FBS, Blank), ET-1, and fluoxetine with (ET-1+F) and without ET-1(F) for 
(ET-1+F) and without ET-1(F) for 72 hours. Data, normalized to the amount of 
72 h. Data, normalized to the amount of actin, are expressed as mean±SEM 
GAPDH, are expressed as mean±SEM (n=7). *p<0.05 vs. Blank, †p<0.001 vs. 
(n=9). *p<0.001 vs. Blank, †p<0.001 vs. ET-1. PASMCs, pulmonary arterial 
ET-1, ‡p<0.001 vs. Blank. PASMCs, pulmonary arterial smooth muscle cel s; 
smooth muscle cel s; FBS, fetal bovine serum; ET-1, endothelin-1; GAPDH, 
ET-1, endothelin-1; GAPDH, glyceraldehydes phosphate dehydrogenase; 
glyceraldehydes phosphate dehydrogenase; DMEM, dulbecco's modified 
DMEM, dulbecco's modified eagle medium; SEM, standard error of mean; 
eagle medium; SEM, standard error of mean.
PCR, polymerase chain reaction.
Yonsei Med J http://www.eymj.org Volume 53 Number 4 July 2012
FeiFeng Dai, et al.
Apoptosis ratio (%
Fig. 5. Fluoxetine enhanced the apoptosis ratio in ET-1induced human 
Fig. 6. Fluoxetine enhanced the apoptosis ratio in ET-1induced human 
PASMCs. The result from Flow Cytometry are displayed for the ratio of 
PASMCs. The result from Flow Cytometry are displayed for the ratio of 
apoptosis in the human PASMCs cultured with low-serum DMEM (2% FBS, 
apoptosis in the human PASMCs cultured with low-serum DMEM (2% FBS, 
Blank), ET-1, and fluoxetine with (ET-1+F) and without ET-1(F) for 72 h. 
Blank), ET-1, and fluoxetine with (ET-1+F) and without ET-1(F) for 72 h. Data 
PASMCs, pulmonary artery smooth muscle cel s; FBS, fetal bovine serum; 
are expressed as mean±SEM (n=6). *p<0.01 vs. Blank, †p<0.001 vs. ET-1. 
ET-1, endothelin-1; DMEM, dulbecco's modified eagle medium; PI, 
PASMCs, pulmonary artery smooth muscle cel s; FBS, fetal bovine serum; 
Propidium Iodide. FITC, fluoresceine isothiocyanate.
ET-1, endothelin-1; DMEM, dulbecco's modified eagle medium; SEM, stan-
dard error of mean.
the processes of proliferation and apoptosis. Results from 
the fluoxetine treatment group in contrast with the ET-1 in-
semiquantitative RT-PCR analysis showed that the mRNA 
duced group (4.85±0.3852 vs. 1.1±0.1634, p<0.001). Also, 
expression of Kv1.5 in ET-1 induced human PASMCs was 
there were no obvious changes between the Blank and fluox-
decreased remarkably, similar to the protein expression seen 
etine only groups (2.2±0.1707 vs. 2.3834±0.0703, p>0.05).
with the Western blots. In Fig. 3, ET-1 significantly decreased the expression of Kv1.5 mRNA compared with the Blank 
(0.0303±0.0034 vs. 0.0661±0.0051, p<0.05), as wel as the Kv1.5 protein (1.2198±0.1016 vs. 2.5717±0.1557, p<0.001), as seen in Fig. 4. Compared with the ET-1 induced group, 
Pulmonary arterial hypertension is characterized by elevated 
the same mRNA and protein were increased remarkably in 
pulmonary vascular resistance, smooth muscle remodeling 
the fluoxetine treatment group (0.1648±0.0087 vs. 0.0303± 
and apoptosis, leading to right heart failure and death.4,12 Lu-
0.0034, p<0.001; 2.1234±0.1766 vs. 1.2198±0.1016, sepa-
men narrowing and medial hypertrophy of smal -sized pul-
rately, p<0.001). Although the Kv1.5 mRNA level was in-
monary arteries are hal marks of the pulmonary vascular re-
creased in the F group, compared with the Blank (0.1305± 
modeling process, which are mainly due to an increased 
0.01478 vs. 0.0661±0.0051, p<0.01), the expression of 
number of pulmonary arterial smooth muscle cel s.13,14 The 
Kv1.5 protein demonstrated no difference (2.5717±0.1557 
imbalance between proliferation and apoptosis results in an 
vs. 2.2290±0.0337, p>0.05). 
augmentation on the number of PASMCs.4 Therefore, pre-cise control of the balance between PASMC proliferation and 
Fluoxetine promotes the apoptosis ratio of ET-1 
apoptosis is important to maintaining the structural and func-
induced human PASMCs
tional integrity of the pulmonary vasculature. Guignabert, et 
The early stages of apoptosis in the human PASMCs treated 
al.9 confirmed the efficacy of fluoxetine in preventing and re-
above were detected by Flow Cytometry. Compared with the 
versing pulmonary vascular remodeling in rats, which made 
Blank, as shown in Fig. 5 and Fig. 6, ET-1 induced apoptosis 
fluoxetine a novel speculative therapeutic option for PAH. 
inhibition was enhanced (1.1±0.1634 vs. 2.3834±0.0703, 
The protection of fluoxetine against PAH in MCT-induced 
p<0.01). Apparently, the apoptosis ratio was increased in 
rats was also previously demonstrated.10,11 In the present 
Yonsei Med J http://www.eymj.org Volume 53 Number 4 July 2012
Fluoxetine Rescues Kv1.5
study, fluoxetine suppressed proliferation and enhanced 
stages was decreased, paral eling with the downregulation 
apoptosis, reversing the imbalance between proliferation and 
of Kv1.5 channels. Impressively, the human PASMCs treat-
apoptosis in human PASMCs induced by ET-1 in vitro.
ed with fluoxetine only changed in the mRNA expression 
Pulmonary Kv channels are thought to play a crucial role 
of Kv1.5, but no changes on the expression of protein was 
in the maintenance of resting membrane potentials, and 
observed, paralleling with the apoptosis ratio, compared 
subsequently the vascular tone of pulmonary arteries. Alter-
ations in Kv channel function lead to several additional and 
A detailed mechanism of the development of PAH is not 
interrelated consequences, including the regulation of cel 
yet known. The results from the present study showed that 
proliferation and apoptosis, which ultimately leads to pul-
fluoxetine plays an important role in rescuing the expres-
monary vascular remodeling. It has been shown that dys-
sion of Kv1.5 channel in the ET-1 induced group. Potential-
function of Kv channels is closely linked to pulmonary vaso-
ly, the pharmacological blockade of 5-HTT may inhibit the 
constriction and pulmonary vascular remodeling in PAH.9,15 
activation of Ras/Rac system, down regulating the levels of 
It was also becoming evident that proliferation of cultured 
TRPC1 and [Ca2+]i and rescue Kv1.5 channels.
human PASMCs was associated with membrane depolar-
In conclusion, fluoxetine plays an important role in im-
ization and down regulation of Kv currents.16 As shown in 
proving pulmonary vascular remodeling, by suppressing pro-
human and animal models of PAH, resistance to apoptosis 
liferation, rescuing Kv1.5 channels and promoting apoptosis.
was further enhanced by the selective down regulation of Kv1.5 channels.1-3 A similar phenomenon was also observed 
in persistent pulmonary hypertension of newborns.17 How-ever, increases in Kv channel activity and expression has 
1. Bonnet S, Rochefort G, Sutendra G, Archer SL, Haromy A, Web-
been widely associated with apoptotic induction. And a pre-
ster L, et al. The nuclear factor of activated T cel s in pulmonary 
vious study confirmed that the up regulation of Kv1.5 was 
arterial hypertension can be therapeutically targeted. Proc Natl 
correlated with an increase in the apoptosis/ proliferation 
Acad Sci U S A 2007;104:11418-23.
ratio and inhibition of PAH.1,4 The available evidence pre-
2. Remil ard CV, Tigno DD, Platoshyn O, Burg ED, Brevnova EE, 
Conger D, et al. Function of Kv1.5 channels and genetic varia-
sented to this point was quite strong regarding the role of 
tions of KCNA5 in patients with idiopathic pulmonary arterial hy-
Kv channels in vascular smooth muscle cel apoptosis. Con-
pertension. Am J Physiol Cel Physiol 2007;292:C1837-53.
versely, there was also mounting evidence that Kv channel 
3. Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, 
Thébaud B, Bonnet S, et al. An abnormal mitochondrial-hypoxia 
activation may also play a significant role in promoting 
inducible factor-1alpha-Kv channel pathway disrupts oxygen 
proliferation.18 
sensing and triggers pulmonary arterial hypertension in fawn 
In the present study, the expression of the TRPC1 mark-
hooded rats: similarities to human pulmonary arterial hyperten-
edly increased in the ET-1 induced group compared with 
sion. Circulation 2006;113:2630-41.
4. McMurtry MS, Bonnet S, Wu X, Dyck JR, Haromy A, Hashimoto 
the Blank, and the expressions of Kv1.5 were decreased 
K, et al. Dichloroacetate prevents and reverses pulmonary hyper-
both in the levels of transcription and translation. Previous-
tension by inducing pulmonary artery smooth muscle cel apopto-
ly, reports demonstrated that [Ca2+]i inhibited K+ channels 
sis. Circ Res 2004;95:830-40.
5. Michel RP, Langleben D, Dupuis J. The endothelin system in pul-
in canine pulmonary arteries,19 and it had also been reported 
monary hypertension. Can J Physiol Pharmacol 2003;81:542-54.
that ET-1 induced-increases of [Ca2+]i were mainly caused 
6. Rubens C, Ewert R, Halank M, Wensel R, Orzechowski HD, 
by its upregulation of transient receptor potential channels 
Schultheiss HP, et al. Big endothelin-1 and endothelin-1 plasma 
(TRPC), especial y TRPC1.20 And, when treated with fluox-
levels are correlated with the severity of primary pulmonary hy-
pertension. Chest 2001;120:1562-9.
etine, it was found that fluoxetine down regulated TRPC1 
7. Shimoda LA, Sylvester JT, Booth GM, Shimoda TH, Meeker S, 
and rescued ET-1 induced Kv1.5 down-regulation in the 
Undem BJ, et al. Inhibition of voltage-gated K(+) currents by en-
levels of transcription and translation and promoted apopto-
dothelin-1 in human pulmonary arterial myocytes. Am J Physiol 
Lung Cel Mol Physiol 2001;281:L1115-22.
sis in human PASMCs in vitro. The results from the present 
8. Marcos E, Adnot S, Pham MH, Nosjean A, Raffestin B, Hamon 
study demonstrated that the upregulation of TRPC1 down 
M, et al. Serotonin transporter inhibitors protect against hypoxic 
regulated the expression of Kv1.5 protein and mRNA in 
pulmonary hypertension. Am J Respir Crit Care Med 2003;168: 
human PASMCs induced by ET-1, potential y by regulating 
9. Guignabert C, Raffestin B, Benferhat R, Raoul W, Zadigue P, 
the intracellular concentrations of Ca2+ in vitro. Further-
Rideau D, et al. Serotonin transporter inhibition prevents and re-
more, compared with the Blank, the apoptosis ratio of early 
verses monocrotaline-induced pulmonary hypertension in rats. 
Yonsei Med J http://www.eymj.org Volume 53 Number 4 July 2012
FeiFeng Dai, et al.
ulation of pulmonary artery smooth muscle cel proliferation and 
10. Zhu SP, Mao ZF, Huang J, Wang JY. Continuous fluoxetine ad-
apoptosis: pharmacotherapeutic implications. Br J Pharmacol 
ministration prevents recurrence of pulmonary arterial hyperten-
2008;153 Suppl 1:S99-111.
sion and prolongs survival in rats. Clin Exp Pharmacol Physiol 
16. Platoshyn O, Golovina VA, Bailey CL, Limsuwan A, Krick S, Ju-
haszova M, et al. Sustained membrane depolarization and pulmo-
11. Zhai FG, Zhang XH, Wang HL. Fluoxetine protects against 
nary artery smooth muscle cel proliferation. Am J Physiol Cel 
monocrotaline-induced pulmonary arterial hypertension: potential 
roles of induction of apoptosis and upregulation of Kv1.5 chan-
17. Konduri GG, Bakhutashvili I, Eis A, Gauthier KM. Impaired volt-
nels in rats. Clin Exp Pharmacol Physiol 2009;36:850-6.
age gated potassium channel responses in a fetal lamb model of 
12. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J 
persistent pulmonary hypertension of the newborn. Pediatr Res 
13. Fantozzi I, Platoshyn O, Wong AH, Zhang S, Remillard CV, 
18. Neylon CB. Potassium channels and vascular proliferation. Vascul 
Furtado MR, et al. Bone morphogenetic protein-2 upregulates ex-
pression and function of voltage-gated K+ channels in human pul-
19. Post JM, Gelband CH, Hume JR. [Ca2+]i inhibition of K+ chan-
monary artery smooth muscle cel s. Am J Physiol Lung Cel Mol 
nels in canine pulmonary artery. Novel mechanism for hypoxia-
induced membrane depolarization. Circ Res 1995;77:131-9.
14. Krick S, Platoshyn O, McDaniel SS, Rubin LJ, Yuan JX. Aug-
20. Wang C, Wang J, Zhao L, Wang Y, Liu J, Shi L, et al. Sildenafil 
mented K(+) currents and mitochondrial membrane depolarization 
inhibits human pulmonary artery smooth muscle cel proliferation 
in pulmonary artery myocyte apoptosis. Am J Physiol Lung Cel 
by decreasing capacitative Ca2+ entry. J Pharmacol Sci 2008;108: 
Mol Physiol 2001;281:L887-94.
15. Burg ED, Remil ard CV, Yuan JX. Potassium channels in the reg-
Yonsei Med J http://www.eymj.org Volume 53 Number 4 July 2012
Source: http://www.eymj.org/Synapse/Data/PDFData/0069YMJ/ymj-53-842.pdf
   Ciencia y Tecnología: el riesgo del abandono  Jorge Labarreda González.  Algo que todo mundo sabe es que no hay mejor medicina para combatir las  enfermedades que la prevención. De manera lógica se deduce: la fortaleza de una  sociedad depende en gran parte de las medidas que tome para hacer frente a la  contingencia, entendida esta, como todo aquello que se encuentra latente, con la 
    Guideline for oral healthcare of adults with Huntington's disease Graham Manley1, Helen Lane1, Annette Carlsson2, Bitte Ahlborg2, Åsa Mårtensson2, Monica B Nilsson2, Sheila A Simpson3,4 & Daniela Rae*3,4; On behalf of the contributing members of the European Huntington's Disease Networks Standards of Care Dental Care Group A preventive dentistry regime should be implemented at the earliest possible opportunity and maintained throughout development of the condition. The use of high fluoride toothpaste is essential.